Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.930
-0.050 (-2.53%)
At close: Sep 12, 2025, 4:00 PM EDT
1.901
-0.029 (-1.51%)
After-hours: Sep 12, 2025, 5:58 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $114.85 million as of September 12, 2025. Its market cap has decreased by -59.44% in one year.
Market Cap
114.85M
Enterprise Value
65.68M
1-Year Change
-59.44%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $114.85M, a decrease of -76.52%. That is a compound annual growth rate of -28.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 117.83M | -16.20% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | 489.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.85B |
| Johnson & Johnson | 426.18B |
| AbbVie | 371.72B |
| UnitedHealth Group | 315.10B |
| AstraZeneca | 251.31B |
| Novartis AG | 248.23B |
| Novo Nordisk | 236.38B |
| Abbott Laboratories | 229.65B |